Malic Acid

Malic Acid

SCHEMBL163388

O=C([O-])CC(O)C(=O)[O-].[Mg+2]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SCSF1RDRD2FLT1FLT3FLT4HTR1BHTR1DHTR1FKDRKITMETOPRD1OPRK1OPRM1PDGFRAPDGFRBRET

The experimentally established mechanism targets of Malic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CA4 P22748 4/20 0.94
CTSL P07711 1/20 0.46
CA2 P00918 1/20 0.43
SLC22A16 Q86VW1 1/20 0.42
CPT2 P23786 1/20 0.34
CPT1A P50416 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
CASP1 P29466 1/20 0.32
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malic Acid SCHEMBL674137 1.00 CA4 (0.94) CA4CTSLCA2SLC22A16CPT2
Malic Acid SCHEMBL29152424 0.97 CA4 (0.89) CA4CTSLCA2SLC22A16CPT2
Malic Acid SCHEMBL4347204 0.97 CA4 (0.89) CA4CTSLCA2SLC22A16CPT2
Malic Acid SCHEMBL29152416 0.97 CA4 (0.89) CA4CTSLCA2SLC22A16CPT2
Malic Acid SCHEMBL29107242 0.97 CA4 (0.89) CA4CTSLCA2SLC22A16CPT2
Malic Acid SCHEMBL18393648 0.94 CA4 (0.94) CA4CTSLCA2SLC22A16CPT2
Malic Acid SCHEMBL21815634 0.94 CA4 (0.94) CA4CTSLCA2SLC22A16CPT2
Malic Acid SCHEMBL18981017 0.94 CA4 (0.94) CA4CTSLCA2SLC22A16CPT2
Malic Acid SCHEMBL21815132 0.94 CA4 (1.00) CA4CTSLCA2SLC22A16CPT2
Malic Acid SCHEMBL20994738 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1553 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026105164-A1 NON-AQUEOUS LIQUID FORMULATIONS OF TETRACYCLINE ANTIBIOTICS ETICO LIFESCIENCES PRIVATE LIMITED (IN) 2026-05-21 WO claimed
CN-122030601-A Composition of plant extract and akkermansia muciniphila and application of composition in improving intestinal health 南京北极光生物科技有限公司 2026-05-15 CN claimed
EP-4735008-A1 IBOGAINE TREATMENT Ambio Life Sciences Inc. (CA) 2026-05-06 EP claimed
US-12582149-B1 Functional additive for hot beverages and foods MILJKOVIC IGOR (US) 2026-03-24 US claimed
US-20260069910-A1 ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL SOLUTIONS AND METHODS OF AND APPARATUS FOR APPLYING THE SAME TO PROTECT PROPERTY AGAINST WILDFIRE MIGHTY FIRE BREAKER LLC (US) 2026-03-12 US claimed
US-20260069911-A1 ENVIRONMENTALLY-CLEAN FIRE INHIBITING BIOCHEMICAL COMPOSITIONS, SOLUTIONS AND POWDERS, AND METHODS OF AND APPARATUS FOR PRODUCING FIRE PROTECTED WOOD PRODUCTS MIGHTY FIRE BREAKER LLC (US) 2026-03-12 US claimed
US-20260048289-A1 ENVIRONMENTALLY-SAFE WATER-BASED FIRE RETARDANT BIOCHEMICAL COMPOSITIONS FORMULATED USING ALKALI METAL SALTS, FREE FROM PHOSPHATES, NITRATES, AND AMMONIUM-SALTS, FOR NON-CORROSIVE AERIAL AND GROUND DELIVERY ONTO PROPERTY REQUIRING LONG-TERM PROTECTION AGAINST WILDFIRE MIGHTY FIRE BREAKER LLC (US) 2026-02-19 US claimed
US-20260034171-A1 Composition for Improving Cognitive Function PERRY STEPHEN C (US) 2026-02-05 US claimed
US-12527813-B2 Methods to stabilize and reverse atherosclerotic lesions by sulfated polysaccharides CALROY HEALTH SCIENCES, LLC (US) 2026-01-20 US claimed
US-20260014403-A1 ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL COMPOSITIONS, SOLUTIONS, POWDERS AND METHODS OF AND APPARATUS FOR PRODUCING FIRE PROTECTED WOOD AND ENGINEERED WOOD PRODUCTS MIGHTY FIRE BREAKER LLC (US) 2026-01-15 US claimed
WO-2004075657-A2 METHOD FOR REDUCING ACRYLAMIDE FORMATION IN THERMALLY PROCESSED FOODS FRITO-LAY NORTH AMERICA, INC. (US) 2004-09-10 WO claimed
US-20040058045-A1 Method for reducing acrylamide formation in thermally processed foods FRITO-LAY NORTH AMERICA, INC. 2004-03-25 US claimed
US-20030211172-A1 Composition and method for substantially reducing the deleterious effects of alcohol on the body JONES JEREMY PARK (US) 2003-11-13 US claimed
US-6589555-B2 Effervescent vitaceutical compositions and related methods PANDYA MAHENDRA (US) 2003-07-08 US claimed
US-20030099724-A1 Compounds for prevention of diabetic retinopathy TURNER OLIVER E (US) 2003-05-29 US claimed
US-6447809-B1 MIXTURES OF MICROCRYSTALLINE HYDROXYAPATITE, CHOLECALCIFEROL AND IPRIFLAVONE ADMINISTERED AS OSTEOBLASTS STIMULANTS FOR PREVENTION OF OSTEOPOROSIS METAGENICS, INC. 2002-09-10 US claimed
US-20010051134-A1 Effervescent vitaceutical compositions and related methods PANDYA MAHENDRA (US) 2001-12-13 US claimed
US-6042849-A FOR TREATMENT OF CONDITIONS ASSOCIATED WITH THE CONSTRICTION OF SMALL BLOOD VESSELS SUCH AS ATHEROGENESIS, HEART ATTACK, STROKE, HYPERTENSION, GLAUCOMA, MIGRAINE, HYPERTENSION OF PREGNANCY, AND DIABETES MELLITUS CHRONORX, LLC (US) 2000-03-28 US claimed
US-5849338-A Unit dosage forms for treatment of vasoconstriction and related conditions CHRONORX LLC (US) 1998-12-15 US claimed
WO-1997037670-A1 UNIT DOSAGE FORMS, CONTAINING MAGNESIUM, VITAMIN C, VITAMIN E, FOLATE AND SELENIUM, FOR TREATMENT OF VASOCONSTRICTION AND RELATED CONDITIONS CHRONORX, LLC (US) 1997-10-16 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260034171-A1 Composition for Improving Cognitive Function PHOSPHO1, PSEN1, S100B CA4 4082/4885CTSL 3149/4885CA2 1359/4885
US-20260069910-A1 ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL SOLUTIONS AND METHODS OF AND APPARATUS FOR APPLYING THE SAME TO PROTECT PROPERTY AGAINST WILDFIRE CA2, CA1, CA7 CA4 10/4885CTSL 972/4885CA2 1/4885
US-12582149-B1 Functional additive for hot beverages and foods SOD1, KCNN1, KCNN3 CA4 192/4885CTSL 2868/4885CA2 6/4885
US-12527813-B2 Methods to stabilize and reverse atherosclerotic lesions by sulfated polysaccharides RPS4Y1, PF4, PKD1 CA4 693/4885CTSL 1873/4885CA2 2391/4885
US-20260014403-A1 ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL COMPOSITIONS, SOLUTIONS, POWDERS AND METHODS OF AND APPARATUS FOR PRODUCING FIRE PROTECTED WOOD AND ENGINEERED WOOD PRODUCTS ME1, ATP6V1A, ATP5MF CA4 47/4885CTSL 1340/4885CA2 12/4885
US-20260048289-A1 ENVIRONMENTALLY-SAFE WATER-BASED FIRE RETARDANT BIOCHEMICAL COMPOSITIONS FORMULATED USING ALKALI METAL SALTS, FREE FROM PHOSPHATES, NITRATES, AND AMMONIUM-SALTS, FOR NON-CORROSIVE AERIAL AND GROUND DELIVERY ONTO PROPERTY REQUIRING LONG-TERM PROTECTION AGAINST WILDFIRE CA3, CA2, FIBP CA4 20/4885CTSL 3632/4885CA2 2/4885
US-20260069911-A1 ENVIRONMENTALLY-CLEAN FIRE INHIBITING BIOCHEMICAL COMPOSITIONS, SOLUTIONS AND POWDERS, AND METHODS OF AND APPARATUS FOR PRODUCING FIRE PROTECTED WOOD PRODUCTS FGB, ACTB, FOSB CA4 86/4885CTSL 933/4885CA2 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.